Related Experiment Video
Updated: Oct 2, 2026

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
[Infection hypothesis of coronary heart disease]
1Medizinische Klinik II, Medizinische Universität Lübeck, Ratzeburger Allee 160, D-23538 Lübeck, Deutschland. jahn@medinf.mu-luebeck.de
Insights
Chlamydia pneumoniae may cause or accelerate coronary artery disease (CAD). Evidence suggests this bacterium is involved in atherosclerosis, a key factor in CAD development and progression.
Area of Science:
- Cardiovascular Science
- Infectious Disease Epidemiology
- Microbiology
Context:
- Coronary artery disease (CAD) is strongly associated with inflammation.
- The exact cause of this inflammation (infectious vs. metabolic/toxic) remains debated.
- Chlamydia pneumoniae is a leading candidate infectious agent implicated in atherosclerosis.
Purpose:
- To review the current understanding of bacterial infection's role in coronary artery disease (CAD) development and progression.
- To evaluate the evidence linking Chlamydia pneumoniae to atherosclerosis and CAD.
- To summarize findings from seroepidemiologic studies and direct bacterial detection in vascular lesions.
Summary:
- Chlamydia pneumoniae is the most probable bacterial agent contributing to atherosclerosis.
- Evidence includes seroepidemiologic data and isolation of the bacteria from vascular lesions.
- This review consolidates current knowledge on the link between bacterial infection and CAD.
Impact:
- Highlights the potential role of Chlamydia pneumoniae in CAD pathogenesis.
- Informs future research directions for understanding CAD etiology.
- May influence diagnostic and therapeutic strategies for coronary artery disease.
Abstract:
It is well accepted that coronary artery disease is linked to an inflammatory process. It is unproven however whether either infectious agents may cause or accelerate coronary artery disease or the inflammatory process is due to metabolic or toxic effects. Among the possible infectious agents Chlamydia pneumoniae is the most likely bacterium involved in atherosclerosis. The arguments in favour of Chlamydia pneumoniae originate from seroepidemiologic studies and from detection and isolation of bacteria from vascular lesions. This review summarises the present understanding of the role of bacterial infection for development or progression of coronary artery disease.
Related Concept Videos
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease I: Introduction
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin create...
Myocarditis I: Introduction
Endocarditis I: Introduction
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations